Cargando…

Refining Clinical Phenotypes to Improve Clinical Decision Support and Reduce Alert Fatigue: A Feasibility Study

Background  Chronic kidney disease (CKD) is common and associated with adverse clinical outcomes. Most care for early CKD is provided in primary care, including hypertension (HTN) management. Computerized clinical decision support (CDS) can improve the quality of care for CKD but can also cause aler...

Descripción completa

Detalles Bibliográficos
Autores principales: Samal, Lipika, Wu, Edward, Aaron, Skye, Kilgallon, John L., Gannon, Michael, McCoy, Allison, Blecker, Saul, Dykes, Patricia C., Bates, David W., Lipsitz, Stuart, Wright, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338104/
https://www.ncbi.nlm.nih.gov/pubmed/37437601
http://dx.doi.org/10.1055/s-0043-1768994
_version_ 1785145934413299712
author Samal, Lipika
Wu, Edward
Aaron, Skye
Kilgallon, John L.
Gannon, Michael
McCoy, Allison
Blecker, Saul
Dykes, Patricia C.
Bates, David W.
Lipsitz, Stuart
Wright, Adam
author_facet Samal, Lipika
Wu, Edward
Aaron, Skye
Kilgallon, John L.
Gannon, Michael
McCoy, Allison
Blecker, Saul
Dykes, Patricia C.
Bates, David W.
Lipsitz, Stuart
Wright, Adam
author_sort Samal, Lipika
collection PubMed
description Background  Chronic kidney disease (CKD) is common and associated with adverse clinical outcomes. Most care for early CKD is provided in primary care, including hypertension (HTN) management. Computerized clinical decision support (CDS) can improve the quality of care for CKD but can also cause alert fatigue for primary care physicians (PCPs). Computable phenotypes (CPs) are algorithms to identify disease populations using, for example, specific laboratory data criteria. Objectives  Our objective was to determine the feasibility of implementation of CDS alerts by developing CPs and estimating potential alert burden. Methods  We utilized clinical guidelines to develop a set of five CPs for patients with stage 3 to 4 CKD, uncontrolled HTN, and indications for initiation or titration of guideline-recommended antihypertensive agents. We then conducted an iterative data analytic process consisting of database queries, data validation, and subject matter expert discussion, to make iterative changes to the CPs. We estimated the potential alert burden to make final decisions about the scope of the CDS alerts. Specifically, the number of times that each alert could fire was limited to once per patient. Results  In our primary care network, there were 239,339 encounters for 105,992 primary care patients between April 1, 2018 and April 1, 2019. Of these patients, 9,081 (8.6%) had stage 3 and 4 CKD. Almost half of the CKD patients, 4,191 patients, also had uncontrolled HTN. The majority of CKD patients were female, elderly, white, and English-speaking. We estimated that 5,369 alerts would fire if alerts were triggered multiple times per patient, with a mean number of alerts shown to each PCP ranging from 0.07–to 0.17 alerts per week. Conclusion  Development of CPs and estimation of alert burden allows researchers to iteratively fine-tune CDS prior to implementation. This method of assessment can help organizations balance the tradeoff between standardization of care and alert fatigue.
format Online
Article
Text
id pubmed-10338104
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-103381042023-11-27 Refining Clinical Phenotypes to Improve Clinical Decision Support and Reduce Alert Fatigue: A Feasibility Study Samal, Lipika Wu, Edward Aaron, Skye Kilgallon, John L. Gannon, Michael McCoy, Allison Blecker, Saul Dykes, Patricia C. Bates, David W. Lipsitz, Stuart Wright, Adam Appl Clin Inform Background  Chronic kidney disease (CKD) is common and associated with adverse clinical outcomes. Most care for early CKD is provided in primary care, including hypertension (HTN) management. Computerized clinical decision support (CDS) can improve the quality of care for CKD but can also cause alert fatigue for primary care physicians (PCPs). Computable phenotypes (CPs) are algorithms to identify disease populations using, for example, specific laboratory data criteria. Objectives  Our objective was to determine the feasibility of implementation of CDS alerts by developing CPs and estimating potential alert burden. Methods  We utilized clinical guidelines to develop a set of five CPs for patients with stage 3 to 4 CKD, uncontrolled HTN, and indications for initiation or titration of guideline-recommended antihypertensive agents. We then conducted an iterative data analytic process consisting of database queries, data validation, and subject matter expert discussion, to make iterative changes to the CPs. We estimated the potential alert burden to make final decisions about the scope of the CDS alerts. Specifically, the number of times that each alert could fire was limited to once per patient. Results  In our primary care network, there were 239,339 encounters for 105,992 primary care patients between April 1, 2018 and April 1, 2019. Of these patients, 9,081 (8.6%) had stage 3 and 4 CKD. Almost half of the CKD patients, 4,191 patients, also had uncontrolled HTN. The majority of CKD patients were female, elderly, white, and English-speaking. We estimated that 5,369 alerts would fire if alerts were triggered multiple times per patient, with a mean number of alerts shown to each PCP ranging from 0.07–to 0.17 alerts per week. Conclusion  Development of CPs and estimation of alert burden allows researchers to iteratively fine-tune CDS prior to implementation. This method of assessment can help organizations balance the tradeoff between standardization of care and alert fatigue. Georg Thieme Verlag KG 2023-07-12 /pmc/articles/PMC10338104/ /pubmed/37437601 http://dx.doi.org/10.1055/s-0043-1768994 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Samal, Lipika
Wu, Edward
Aaron, Skye
Kilgallon, John L.
Gannon, Michael
McCoy, Allison
Blecker, Saul
Dykes, Patricia C.
Bates, David W.
Lipsitz, Stuart
Wright, Adam
Refining Clinical Phenotypes to Improve Clinical Decision Support and Reduce Alert Fatigue: A Feasibility Study
title Refining Clinical Phenotypes to Improve Clinical Decision Support and Reduce Alert Fatigue: A Feasibility Study
title_full Refining Clinical Phenotypes to Improve Clinical Decision Support and Reduce Alert Fatigue: A Feasibility Study
title_fullStr Refining Clinical Phenotypes to Improve Clinical Decision Support and Reduce Alert Fatigue: A Feasibility Study
title_full_unstemmed Refining Clinical Phenotypes to Improve Clinical Decision Support and Reduce Alert Fatigue: A Feasibility Study
title_short Refining Clinical Phenotypes to Improve Clinical Decision Support and Reduce Alert Fatigue: A Feasibility Study
title_sort refining clinical phenotypes to improve clinical decision support and reduce alert fatigue: a feasibility study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338104/
https://www.ncbi.nlm.nih.gov/pubmed/37437601
http://dx.doi.org/10.1055/s-0043-1768994
work_keys_str_mv AT samallipika refiningclinicalphenotypestoimproveclinicaldecisionsupportandreducealertfatigueafeasibilitystudy
AT wuedward refiningclinicalphenotypestoimproveclinicaldecisionsupportandreducealertfatigueafeasibilitystudy
AT aaronskye refiningclinicalphenotypestoimproveclinicaldecisionsupportandreducealertfatigueafeasibilitystudy
AT kilgallonjohnl refiningclinicalphenotypestoimproveclinicaldecisionsupportandreducealertfatigueafeasibilitystudy
AT gannonmichael refiningclinicalphenotypestoimproveclinicaldecisionsupportandreducealertfatigueafeasibilitystudy
AT mccoyallison refiningclinicalphenotypestoimproveclinicaldecisionsupportandreducealertfatigueafeasibilitystudy
AT bleckersaul refiningclinicalphenotypestoimproveclinicaldecisionsupportandreducealertfatigueafeasibilitystudy
AT dykespatriciac refiningclinicalphenotypestoimproveclinicaldecisionsupportandreducealertfatigueafeasibilitystudy
AT batesdavidw refiningclinicalphenotypestoimproveclinicaldecisionsupportandreducealertfatigueafeasibilitystudy
AT lipsitzstuart refiningclinicalphenotypestoimproveclinicaldecisionsupportandreducealertfatigueafeasibilitystudy
AT wrightadam refiningclinicalphenotypestoimproveclinicaldecisionsupportandreducealertfatigueafeasibilitystudy